Article

Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.

Memorial University of Newfoundland.
Canadian Medical Association Journal (Impact Factor: 5.81). 06/1997; 156(9):1273-87.
Source: PubMed

ABSTRACT To provide physicians and allied health care professionals with guidelines for the diagnosis and management of migraine in clinical practice.
The full range and quality of diagnostic and therapeutic methods available for the management of migraine.
Improvement in the diagnosis and treatment of migraine, which will lead to a reduction in suffering, increased productivity and decreased economic burden. EVIDENCE AND VALUES: The creation of the guidelines followed a needs assessment by members of the Canadian Headache Society and included a statement of objectives; development of guidelines by multidisciplinary working groups using information from literature reviews and other resources; comparison of alternative clinical pathways and description of how published data were analysed; definition of the level of evidence for data in each case; evaluation and revision of the guidelines at a consensus conference held in Ottawa on Oct. 27-29, 1995; redrafting and insertion of tables showing key variables and data from various studies and tables of data with recommendations; and reassessment by all conference participants.
Accuracy in diagnosis is a major factor in improving therapeutic effectiveness. Improvement in the precise diagnosis of migraine, coupled with a rational plan for the treatment of acute attacks and for prophylactic therapy, is likely to lead to substantial benefits in both human and economic terms.
The diagnosis of migraine can be improved by using modified criteria of the International Headache Society as well as a semistructured patient interview technique. Appropriate treatment of symptoms should take into account the severity of the migraine attack, since most patients will have attacks of differing severity and can learn to use medication appropriate for each attack. When headaches are frequent or particularly severe, prophylactic therapy should be considered. Both the avoidance of migraine trigger factors and the application of nonpharmacological therapies play important roles in overall migraine management and will be addressed at a later date.
The guidelines are based on consensus of Canadian experts in neurology, emergency medicine, psychiatry, psychology, family medicine and pharmacology, and consumers. Previous guidelines did not exist. Field testing of the guidelines is in progress.

Download full-text

Full-text

Available from: R. Allan Purdy, Jul 27, 2015
0 Followers
 · 
166 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To provide physicians and allied health care professionals with guidelines for the nonpharmacologic management of migraine in clinical practice. The full range and quality of nonpharmacologic therapies available for the management of migraine. Improvement in the nonpharmacologic management of migraine. EVIDENCE AND VALUES: The creation of the guidelines followed a needs assessment by members of the Canadian Headache Society and included a statement of objectives; development of guidelines by multidisciplinary working groups using information from literature reviews and other resources; comparison of alternative clinical pathways and description of how published data were analysed; definition of the level of evidence for data in each case; evaluation and revision of the guidelines at a consensus conference held in Ottawa on Oct. 27-29, 1995; redrafting and insertion of tables showing key variables and data from various studies and tables of data with recommendations; and reassessment by all conference participants. Augmentation of the use of nonpharmacologic therapies for the acute and prophylactic management of migraine is likely to lead to substantial benefits in both human and economic terms. Both the avoidance of migraine trigger factors and the use of nonpharmacologic therapies have a part to play in overall migraine management. The guidelines are based on consensus of Canadian experts in neurology, emergency medicine, psychiatry, psychology and family medicine, and consumers. Previous guidelines did not exist. Field testing of the guidelines is in progress.
    Canadian Medical Association Journal 08/1998; 159(1):47-54. · 5.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article reviews how to establish the diagnosis of migraine, the possible differential diagnoses, and the present state of the art of therapy. Emphasis is laid on nonsteroidal antiphlogistic drugs, serotonin receptor agonists (the so called triptans), and antiemetic drugs. The interval therapy consists of beta-blockers, calcium antagonists, antiepileptics, and serotonin receptor antagonists. The pathophysiology is based on the concept of sterile neurogenic inflammation, cortical spreading depression (CSD), and hyperexcitability of the central nervous system (CNS).
    Current Review of Pain 02/1999; 3(3):206-213.
  • Source
    Western Journal of Medicine 12/2000; 173(5):341-5. DOI:10.1136/ewjm.173.5.341
Show more